Watchlist Price Alert

Acceleron Pharma Inc. (XLRN)

NASDAQ: XLRN · Real-Time Price · USD

178.75

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	336.46M	336.2M	455.51M	670.95M	729.68M	283.52M	277.49M	237.68M	169.54M	163.61M	214.49M	144.05M	112.43M	79.59M	69.74M	100.15M	238.96M	30.73M	33.16M	20.95M	31.02M	36.99M	63.68M
Short-Term Investments	254.11M	287.15M	231.74M	178.95M	152.68M	106.29M	136.95M	193.69M	256.53M	267.15M	223.11M	147.26M	195.54M	208.34M	222.12M	177.08M	98.27M	111.69M	108.22M	118.74M	107.28M	83.72M	100.78M
Long-Term Investments	61.95M	89.19M	108.19M	7.58M	5M	n/a	1.12M	22.48M	42.22M	70.16M	75.51M	n/a	11.84M	44.33M	61.49M	95.72M	29.37M	51.62M	71.84M	94.69M	112.73M	142M	114.19M
Other Long-Term Assets	1.54M	1.71M	1.72M	1.73M	1.71M	1.7M	1.68M	1.79M	1.82M	1.67M	1.7M	1.7M	1.69M	1.23M	1.24M	1.25M	1.26M	1.22M	1.15M	968K	952K	1M	1M
Receivables	35.66M	29.72M	25.21M	26.1M	22.56M	39.75M	8.44M	8.55M	6.88M	5.45M	2.78M	7.04M	3.26M	3.67M	3.23M	3.57M	2.88M	2.88M	3.57M	3.23M	3.02M	3.24M	3.06M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	70.37M	64.7M	25.16M	17.27M	8.85M	19.39M	9.28M	10M	10.59M	9.51M	7.9M	7.66M	7.09M	7.52M	5.2M	4.45M	3.33M	3.11M	4.09M	3.86M	3.68M	3.08M	3.17M
Total Current Assets	696.61M	717.77M	737.61M	893.27M	913.78M	448.95M	432.16M	449.92M	443.53M	445.71M	448.27M	306.01M	318.32M	299.12M	300.29M	285.24M	343.44M	148.41M	149.03M	146.79M	144.99M	127.04M	170.69M
Property-Plant & Equipment	27.75M	27.38M	28.27M	29.76M	27.28M	28.79M	29.2M	30.72M	32.1M	33.32M	34.84M	7.11M	6.27M	6.87M	7.02M	6.97M	7.21M	7.21M	7.11M	5.2M	4.21M	4.19M	3.72M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	91.24M	118.28M	138.18M	39.07M	33.99M	30.48M	32M	54.99M	76.13M	105.15M	112.06M	8.81M	19.79M	52.42M	69.74M	103.93M	37.84M	60.05M	80.1M	100.86M	117.89M	147.19M	118.92M
Total Assets	787.85M	836.05M	875.79M	932.34M	947.76M	479.44M	464.16M	504.91M	519.67M	550.87M	560.33M	314.82M	338.12M	351.54M	370.03M	389.18M	381.28M	208.46M	229.13M	247.65M	262.88M	274.23M	289.6M
Account Payables	5.09M	9.44M	4.46M	8.47M	8.86M	12.93M	3.93M	2.29M	1.85M	3.55M	3.93M	419K	1.29M	1.27M	1.68M	1.09M	1.02M	1.66M	911K	1.59M	2.07M	566K	1.2M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	541K	541K	541K	541K	541K	541K	541K	541K
Short-Term Debt	8.16M	7.55M	7.28M	7.01M	6.52M	6.47M	6.41M	6.18M	5.96M	5.75M	5.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	44.12M	42.49M	38.07M	44.68M	21.92M	17.97M	18.19M	24.89M	23.82M	16.76M	13.8M	18.49M	13.39M	13.3M	11.27M	15.12M	14.32M	12.1M	13.74M	14.02M	13.58M	12.59M	13.44M
Total Current Liabilities	57.37M	59.48M	49.82M	60.16M	37.3M	37.36M	28.53M	33.37M	31.64M	26.06M	23.27M	18.91M	14.68M	14.57M	12.94M	16.75M	15.88M	14.3M	15.19M	16.15M	16.19M	13.69M	15.18M
Long-Term Debt	11.95M	13.17M	n/a	n/a	n/a	n/a	n/a	26.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	373K	373K	15.14M	17.07M	15.33M	20.46M	21.81M	-4.33M	23.23M	24.91M	26.52M	3.87M	4.32M	3.86M	3.31M	4.05M	3.56M	2.2M	2.05M	2.2M	13.31M	12.71M	10.04M
Total Long-Term Liabilities	12.32M	13.54M	15.14M	17.07M	15.33M	20.46M	21.81M	22.06M	23.23M	24.91M	26.52M	3.87M	4.32M	3.86M	3.31M	7.21M	6.85M	5.63M	5.62M	5.9M	17.15M	16.68M	14.15M
Total Liabilities	69.69M	73.02M	64.96M	77.23M	52.63M	57.82M	50.34M	55.43M	54.87M	50.97M	49.8M	22.78M	19M	18.43M	16.25M	23.96M	22.74M	19.93M	20.81M	22.05M	33.34M	30.37M	29.32M
Total Debt	20.11M	20.72M	22.43M	24.08M	21.85M	23.41M	24.92M	32.57M	27.81M	29.15M	30.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	61K	61K	60K	60K	60K	54K	53K	53K	54K	53K	53K	47K	47K	47K	46K	46K	45K	39K	39K	39K	38K	38K	38K
Retained Earnings	-1.07B	-1B	-940.91M	-877.44M	-820.04M	-780.8M	-762.35M	-711.41M	-687.83M	-642.46M	-624.6M	-586.55M	-551.82M	-524.48M	-495.54M	-473.02M	-445.1M	-419.65M	-389.98M	-364.49M	-345.2M	-324.43M	-302.42M
Comprehensive Income	-398K	-409K	-417K	-288K	-225K	-83K	-244K	23K	131K	160K	-292K	-560K	-763K	-1.04M	-1.32M	-895K	-314K	-354K	-400K	-425K	-122K	252K	25K
Shareholders Equity	718.15M	763.03M	810.83M	855.11M	895.14M	421.62M	413.82M	449.48M	464.8M	499.9M	510.54M	292.04M	319.11M	333.11M	353.78M	365.22M	358.54M	188.53M	208.32M	225.6M	229.55M	243.86M	260.28M
Total Investments	316.06M	376.35M	339.93M	186.54M	157.68M	106.29M	138.08M	216.17M	298.75M	337.31M	298.62M	147.26M	207.38M	252.67M	283.61M	272.8M	127.64M	163.31M	180.06M	213.43M	220.01M	225.72M	214.97M